On December 28, 2017, the U.S. Food and Drug Administration (FDA) permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers.
Read more via Fda.gov.
Is your Nursing Team an All-Pro Nursing Team? The deadline to enter the 2026 All-Pro Nursing Awards is Monday, March 9th 2026. We want to know how your team has made a difference. Apply now! Also check out last year's winners.
FDA permits marketing of new device for treating diabetic foot ulcers
Share
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
